Biocartis, Debiopharm, Immunexpress Group deal

Immunexpress granted Debiopharm and Biocartis exclusive, worldwide rights to co-develop Immunexpress' SeptiCyte Triage for use in emergency and intensive care units to diagnose sepsis and determine it...